On May 28, 2025, Klotho Neurosciences, Inc. stockholders voted to approve a reverse stock split of their common stock, with the exchange ratio to be set between one-for-2 to one-for-50. During the meeting, 18,977,235 shares were in favor of the proposal, allowing the company to reduce its outstanding shares from 28,510,632.